ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

ACOR Acorda Therapeutics Inc

12.29
0.38 (3.19%)
Last Updated: 00:30:40
Delayed by 15 minutes

Acorda Therapeutics Financial Summary

The current ACOR market cap is 15.27M. The company's latest EPS is USD -53.0683 and P/E is -0.22.

Quarter End Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 38.09M33.32M22.26M29.68M34.83M
Operating Income -4.99M-6.39M-12.57M-4.46M-604k
Net Income -13.85M19.14M-16.82M-9.38M-8.89M
Year End 31 December 2022 20182019202020212022
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 471.43M279.34M183.86M129.07M131.12M
Operating Income 38.49M-311.63M-60.14M-77.31M-42.04M
Net Income 33.68M-272.97M-99.59M-103.95M-65.92M
Quarter End Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Assets 393.34M395.6M374.91M364.7M366.34M
Total Liabilities 317.57M301.97M297.95M296.83M307.39M
Total Equity 75.77M93.62M76.96M67.87M58.96M
Year End 31 December 2022 20182019202020212022
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Assets 1.3B799.72M632.68M455.47M395.6M
Total Liabilities 687.68M488.9M394.73M304.33M301.97M
Total Equity 611.98M310.82M237.96M151.14M93.62M
Quarter End Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Operating -29.99M-20.92M-7.02M-18.57M-10.97M
Investing -260k-136k N/A N/A -220k
Financing N/A N/A N/A N/A N/A
Year End 31 December 2022 20182019202020212022
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Operating 150.79M-128.17M-61.01M-41.35M-20.92M
Investing -176.87M-505k59.36M73.78M-136k
Financing 12.8M-60.55M-1.67M-69.66M N/A
Market Cap 15.27M
Price to Earnings Ratio -0.22
Price to Sales Ratio 0.11
Price to Cash Ratio 0.39
Price to Book Ratio 0.16
Dividend Yield -

Share Statistics

Shares Outstanding 1.24M
Average Volume (1 week) 3.11k
Average Volume (1 Month) 4.53k
52 Week Change 13.61%
52 Week High 24.196
52 Week Low 8.978
Spread (Intraday) 0.61 (4.92%)

Company Info

Company Name Acorda Therapeutics Inc
Address 1209 orange st
wilmington, delaware 19801
Website https://www.acorda.com
Industry biological pds,ex diagnstics (2836)

Your Recent History

Delayed Upgrade Clock